Page last updated: 2024-08-24

nafagrel and 6-ketoprostaglandin f1 alpha

nafagrel has been researched along with 6-ketoprostaglandin f1 alpha in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Echizen, H; Fujiwara, H; Ishizaki, T; Ohnishi, A; Tanaka, T; Yasuda, K1
Matsumoto, K; Ono, S; Takami, M; Takata, Y; Tsukada, W1
Abe, Y; Ashida, S; Irie, K; Kunitada, S; Masumura, H1
Inoue, H; Kawakubo, K; Murakawa, Y; Nozaki, A; Sugimoto, T; Toda, I; Yoshimoto, N1
Ito, M; Nagamatsu, T; Nagao, T; Suzuki, Y1
Homma, M; Ichikawa, Y; Tojo, T; Yoshida, T1
Nagamatsu, T; Nagao, T; Suzuki, Y1
Homma, M; Ikeda, Y; Kameda, H; Masashi, A; Yoshida, T1

Trials

1 trial(s) available for nafagrel and 6-ketoprostaglandin f1 alpha

ArticleYear
Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis.
    Advances in experimental medicine and biology, 1997, Volume: 433

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cross-Over Studies; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Lupus Nephritis; Male; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1997

Other Studies

7 other study(ies) available for nafagrel and 6-ketoprostaglandin f1 alpha

ArticleYear
Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Clinical pharmacology and therapeutics, 1992, Volume: 51, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Chromatography, High Pressure Liquid; Epinephrine; Humans; Imidazoles; Male; Norepinephrine; Physical Exertion; Platelet Aggregation; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1992
Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
    Annals of the New York Academy of Sciences, 1991, Volume: 629

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antigens; Asthma; Bronchoconstriction; Guinea Pigs; Imidazoles; In Vitro Techniques; Lung; Ovalbumin; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1991
A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury.
    European journal of pharmacology, 1991, Feb-14, Volume: 193, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Acute Kidney Injury; Animals; Hydronephrosis; Imidazoles; Ischemia; Kidney; Male; Perfusion; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase

1991
Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Japanese heart journal, 1990, Volume: 31, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Coronary Vessels; Dogs; Electrophysiology; Female; Heart Rate; Heart Ventricles; Imidazoles; Ligation; Male; Naphthalenes; Refractory Period, Electrophysiological; Reperfusion; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase; Ventricular Fibrillation

1990
Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
    European journal of pharmacology, 1994, Jul-11, Volume: 259, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Basement Membrane; Cholesterol; Dinoprostone; Fluorescent Antibody Technique; Imidazoles; Kidney Glomerulus; Male; Methacrylates; Nephritis, Interstitial; Platelet Aggregation; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1994
Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Lupus, 1996, Volume: 5, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Enzyme Inhibitors; Female; Humans; Imidazoles; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Prostaglandins; Reference Values; Regression Analysis; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1996
Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    European journal of pharmacology, 1996, Nov-28, Volume: 316, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antibodies; Azathioprine; Creatinine; Dinoprostone; Drug Interactions; Enzyme Inhibitors; Glomerulonephritis; Imidazoles; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Male; Methacrylates; Proteinuria; Rabbits; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1996